Barnaby Hunt
42PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (42)
Sort by Publication Date:
|Mar 02, 2026
Annual pharmacy cost per patient achieving composite treatment endpoints: a cost to target analysis of tirzepatide versus subcutaneous semaglutide 1 mg in patients with type 2 diabetes in the UK.Naresh Kanumilli, Beatrice Osumili, Jerome Evans
|Dec 20, 2025
Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOW.Peter Rossing, Morten Lindhardt, Christian Klyver Tikkanen
|Nov 12, 2025
Early Change in Proteinuria as a Surrogate Endpoint in Studies of IgA Nephropathy: An Updated Patient-Level Meta-analysis and Discussion of Appropriate Methodology.Nicolas Maillard, Khalil El Karoui, Alex Mercer
|Feb 07, 2025
Correction to: The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.Toshihiko Aranishi, Ataru Igarashi, Kazuo Hara
|Dec 21, 2024
The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.Toshihiko Aranishi, Ataru Igarashi, Kazuo Hara
|Jul 18, 2024
Cost analysis of patiromer vs sodium zirconium cyclosilicate for the treatment of hyperkalemia in Spain and the UK.Antonio Ramirez de Arellano, Gabrielius Jakutis, Barnaby Hunt
Pageof 7
Frequent Collaborators
6 joint publications
Samuel Malkin
4 joint publications
Beatrice Osumili
2 joint publications
Zhihong Cai
2 joint publications
Toshihiko Aranishi
2 joint publications
Stephen C Bain
2 joint publications
Masakazu Takeuchi
2 joint publications
Barrie Chubb
2 joint publications
Manaka Sato
2 joint publications
Ataru Igarashi
2 joint publications
Marc Evans
